Prospective study of oral microbiome and gastric cancer risk among Asian, African American and European American populations.
gastric cancer risk
oral microbiome
shotgun metagenomic sequencing
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
15 03 2022
15 03 2022
Historique:
revised:
22
07
2021
received:
06
05
2021
accepted:
28
07
2021
pubmed:
20
10
2021
medline:
19
2
2022
entrez:
19
10
2021
Statut:
ppublish
Résumé
Colonization of specific bacteria in the human mouth was reported to be associated with gastric cancer risk. However, previous studies were limited by retrospective study designs and low taxonomic resolutions. We performed a prospective case-control study nested within three cohorts to investigate the relationship between oral microbiome and gastric cancer risk. Shotgun metagenomic sequencing was employed to characterize the microbiome in prediagnostic buccal samples from 165 cases and 323 matched controls. Associations of overall microbial richness and abundance of microbial taxa, gene families and metabolic pathways with gastric cancer risk were evaluated via conditional logistic regression. Analyses were performed within each cohort, and results were combined by meta-analyses. We found that overall microbial richness was associated with decreased gastric cancer risk, with an odds ratio (OR) per standard deviation (SD) increase in Simpson's reciprocal index of 0.77 (95% confidence interval [CI] = 0.61-0.99). Nine taxa, 38 gene families and six pathways also showed associations with gastric cancer risk at P < .05. Neisseria mucosa and Prevotella pleuritidis were enriched, while Mycoplasma orale and Eubacterium yurii were depleted among cases with ORs and 95% CIs per SD increase in centered log-ratio transformed taxa abundance of 1.31 (1.03-1.67), 1.26 (1.00-1.57), 0.74 (0.59-0.94) and 0.80 (0.65-0.98), respectively. The top two gene families (P = 3.75 × 10
Identifiants
pubmed: 34664266
doi: 10.1002/ijc.33847
pmc: PMC8982516
mid: NIHMS1789849
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
916-927Subventions
Organisme : NCI NIH HHS
ID : U01CA202979
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA230205
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA173640
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA202979
Pays : United States
Organisme : NCI NIH HHS
ID : UM1CA173640
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA230205
Pays : United States
Organisme : NCI NIH HHS
ID : UM1CA182910
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA207466
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182910
Pays : United States
Organisme : Vanderbilt-Ingram Cancer Center
ID : P30 CA68485
Organisme : NCI NIH HHS
ID : R01 CA204113
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA204113
Pays : United States
Informations de copyright
© 2021 UICC.
Références
Cancers (Basel). 2020 Sep 14;12(9):
pubmed: 32937864
Am J Epidemiol. 2005 Dec 1;162(11):1123-31
pubmed: 16236996
Microbiome. 2017 Mar 3;5(1):27
pubmed: 28253908
Int J Cancer. 2019 May 15;144(10):2381-2389
pubmed: 30365870
J Acad Nutr Diet. 2013 Apr;113(4):569-80
pubmed: 23415502
J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):26-37
pubmed: 20173283
Am J Hum Genet. 2015 May 7;96(5):797-807
pubmed: 25957468
Gastroenterology. 2020 Nov;159(5):1705-1714.e2
pubmed: 32771406
Adv Appl Microbiol. 2016;97:171-210
pubmed: 27926431
Prz Gastroenterol. 2019;14(1):26-38
pubmed: 30944675
Nat Methods. 2018 Nov;15(11):962-968
pubmed: 30377376
Genome Biol. 2019 Nov 28;20(1):257
pubmed: 31779668
Dig Dis Sci. 2021 Sep;66(9):2964-2980
pubmed: 33044677
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):826-34
pubmed: 21357376
Thorax. 2021 Mar;76(3):256-263
pubmed: 33318237
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Cancer Res. 2017 Dec 1;77(23):6777-6787
pubmed: 29196415
Ann Epidemiol. 2016 May;26(5):322-9
pubmed: 27143475
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Sci Rep. 2019 Sep 19;9(1):13589
pubmed: 31537876
Gut. 2018 Jan;67(1):120-127
pubmed: 27742762
Cell. 2019 Aug 8;178(4):779-794
pubmed: 31398336
J Periodontol. 2017 Nov;88(11):1124-1134
pubmed: 28671506
mSystems. 2018 Dec 4;3(6):
pubmed: 30534599
J Cancer. 2018 Oct 17;9(21):4039-4048
pubmed: 30410609
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Gut. 2021 Mar;70(3):620-621
pubmed: 32690603
Int J Cancer. 2018 Nov 1;143(9):2281-2288
pubmed: 29873081
Oncol Rep. 2018 May;39(5):2217-2224
pubmed: 29498406
JAMA Oncol. 2018 Mar 01;4(3):358-365
pubmed: 29327043
Int J Epidemiol. 2015 Jun;44(3):810-8
pubmed: 25733578
Med Princ Pract. 2011;20(4):303-20
pubmed: 21576989
Science. 2009 Dec 18;326(5960):1694-7
pubmed: 19892944
Front Cell Infect Microbiol. 2021 Mar 10;11:640309
pubmed: 33777850
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Nature. 2019 Oct;574(7776):117-121
pubmed: 31534227
JCI Insight. 2019 Mar 7;4(5):
pubmed: 30843879